Tower Research Capital LLC (TRC) - AVID BIOSERVICES INC ownership

AVID BIOSERVICES INC's ticker is CDMO and the CUSIP is 05368M106. A total of 176 filers reported holding AVID BIOSERVICES INC in Q4 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AVID BIOSERVICES INC
ValueSharesWeighting
Q2 2024$85,759
+601.7%
12,011
+558.5%
0.00%
Q1 2024$12,221
-57.5%
1,824
-58.7%
0.00%
Q4 2023$28,730
-11.0%
4,420
+29.3%
0.00%
-100.0%
Q3 2023$32,276
-62.2%
3,419
-44.0%
0.00%
-66.7%
Q2 2023$85,343
+164021.2%
6,109
+117.5%
0.00%
+50.0%
Q1 2023$52
-25.7%
2,809
-45.0%
0.00%
-33.3%
Q4 2022$70
-99.9%
5,105
+35.1%
0.00%
+200.0%
Q3 2022$72,000
-61.9%
3,778
-69.5%
0.00%
-75.0%
Q2 2022$189,000
+455.9%
12,405
+642.4%
0.00%
Q1 2022$34,000
-82.4%
1,671
-74.8%
0.00%
-100.0%
Q4 2021$193,000
-24.3%
6,624
-44.0%
0.00%
-57.1%
Q3 2021$255,000
+311.3%
11,825
+389.4%
0.01%
+250.0%
Q2 2021$62,000
-31.1%
2,416
-50.8%
0.00%0.0%
Q1 2021$90,000
-2.2%
4,911
-38.8%
0.00%
-33.3%
Q4 2020$92,000
-80.1%
8,025
-86.8%
0.00%
-40.0%
Q3 2020$463,000
+486.1%
60,706
+402.0%
0.01%
+66.7%
Q2 2020$79,000
+172.4%
12,094
+127.6%
0.00%
+50.0%
Q3 2019$29,000
-6.5%
5,313
-2.1%
0.00%0.0%
Q2 2019$31,000
-64.8%
5,425
-73.8%
0.00%
-60.0%
Q1 2019$88,000
+2100.0%
20,691
+2232.7%
0.01%
Q4 2018$4,0008870.00%
Other shareholders
AVID BIOSERVICES INC shareholders Q4 2023
NameSharesValueWeighting ↓
ISZO CAPITAL MANAGEMENT LP 2,346,961$50,624,00022.33%
AltraVue Capital, LLC 2,464,316$53,155,0007.86%
Sargent Investment Group, LLC 812,113$17,517,0004.26%
AWM Investment Company, Inc. 1,233,000$26,596,0002.61%
Ranger Investment Management 2,211,560$47,703,0002.54%
Parkman Healthcare Partners LLC 450,000$9,707,0002.46%
Legato Capital Management LLC 305,114$6,581,0001.25%
SNYDER CAPITAL MANAGEMENT L P 1,780,935$38,415,0001.02%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 730,750$15,762,0000.90%
Pier Capital, LLC 361,287$7,793,0000.81%
View complete list of AVID BIOSERVICES INC shareholders